EMA to be given more power and independence in handling COVID-19 pandemic and future health emergencies.  Negotiations between member states and European Parliament are due to begin

Head of EU pharma trade body says waiver would ‘open the door to counterfeit vaccines’ and kill incentives to tackle dangerous virus variants. ‘Who will make the vaccine next time?’ one pharma chief asks

As the problem of COVID-19 vaccines supplies so potently illustrates, it is time to rethink the EU’s pandemic preparedness strategy. More support is needed for late stage clinical development and large scale manufacturing

US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations

Amid pressure to speed up vaccination programmes some member states are starting to go their own way on securing doses. The EU’s head vaccine official says no country can jump the queue

Review of one of the leading vaccine hopes reveals no safety concerns, developers say

Politicians accuse manufacturers of lack of transparency over multi-million deals with Brussels, and raise concerns over exemptions from legal action in case vaccines go wrong

The Innovative Health Initiative will see the scope of joint research between industry, academics and SMEs expand beyond pharmaceuticals, to include medical technology, biotech, digital health and vaccines